PREhabilitation of Frail Elderly PAtients Undergoing majoR surgEry at HOME (PREPARE-HOME) Using Smart Wearables

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorSingapore General Hospital

About this trial

The goal of this clinical trial is to evaluate whether a prehabilitation program using wearable technology can improve physical function and postoperative outcomes in elderly patients (65 years or older) undergoing major elective non-cardiac surgery. The main questions it aims to answer are:

Does the prehabilitation program improve physical function, as measured by the 6-minute walk test (6MWT), from baseline to pre-surgery? Does the prehabilitation program reduce postoperative complications and enhance recovery? Researchers will compare participants who receive the prehabilitation program with wearable technology (intervention group) to those receiving standard preoperative care (control group) to see if the intervention results in greater improvements in physical function and postoperative outcomes.

Participants will:

Follow a personalized exercise program monitored remotely via telemedicine. Wear a Fitbit Aspire 3 device to track vital signs such as heart rate and physical activity.

Undergo assessments of physical function and quality of life before surgery.

Eligibility criteria

Qualifiers

Frail elderly patients aged 65 years or older.

Scheduled to undergo major elective, non-cardiac surgery.

Anticipated surgery duration of over two hours or expected blood loss greater than 500 mL.

Frailty status with Edmonton Frail Scale (EFS) score of 6 or higher.

Disqualifiers

Severe comorbidities that interfere with participation in the exercise program (e.g., unstable angina, severe aortic stenosis, or uncontrolled arrhythmias).

Cognitive impairments that prevent understanding or adherence to the intervention.

Trial design

Treatments tested in this trial

  • Supervised prehabilitation programme

Treatment groups

190 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators